111 related articles for article (PubMed ID: 702321)
1. A study of the effect of delta 9-tetrahydrocannabinol (delta 9-THC) on mammalian salivary flow.
McConnell WR; Dewey WL; Harris LS; Borzelleca JF
J Pharmacol Exp Ther; 1978 Sep; 206(3):567-73. PubMed ID: 702321
[TBL] [Abstract][Full Text] [Related]
2. Effects of delta 9-tetrahydrocannabinol on prostaglandin formation in brain.
Reichman M; Nen W; Hokin LE
Mol Pharmacol; 1987 Nov; 32(5):686-90. PubMed ID: 2824983
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
Pisanu A; Acquas E; Fenu S; Di Chiara G
Neuropharmacology; 2006 May; 50(6):661-70. PubMed ID: 16427098
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and respiratory effects of cannabis in cat and rat.
Graham JD; Li DM
Br J Pharmacol; 1973 Sep; 49(1):1-10. PubMed ID: 4787563
[TBL] [Abstract][Full Text] [Related]
5. Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain.
Tripathi HL; Vocci FJ; Brase DA; Dewey WL
Alcohol Drug Res; 1987; 7(5-6):525-32. PubMed ID: 3620017
[TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
[TBL] [Abstract][Full Text] [Related]
7. Effect of sympathetic stimulation on salivary secretion in submandibular gland in the rabbit stimulated by pilocarpine.
Moreno M; Martínez de Victoria E; López MA
Rev Esp Fisiol; 1984 Mar; 40(1):15-8. PubMed ID: 6147000
[TBL] [Abstract][Full Text] [Related]
8. Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.
Frederickson RC; Hewes CR; Aiken JW
J Pharmacol Exp Ther; 1976 Nov; 199(2):375-84. PubMed ID: 988178
[TBL] [Abstract][Full Text] [Related]
9. The cardiovascular and autonomic effects of repeated administration of delta-9-tetrahydrocannabinol to rhesus monkeys.
Fredericks AB; Benowitz NL; Savanapridi CY
J Pharmacol Exp Ther; 1981 Feb; 216(2):247-53. PubMed ID: 6257883
[TBL] [Abstract][Full Text] [Related]
10. delta 9-Tetrahydrocannabinol decreases turnover of brain histamine.
Oishi R; Itoh Y; Nishibori M; Saeki K
J Pharmacol Exp Ther; 1985 Feb; 232(2):513-8. PubMed ID: 2578567
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
Hirohashi M; Takasuna K; Yamashita N; Tamura K
Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
[TBL] [Abstract][Full Text] [Related]
12. Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heart.
Hillard CJ; Pounds JJ; Boyer DR; Bloom AS
J Pharmacol Exp Ther; 1990 Mar; 252(3):1075-82. PubMed ID: 2156989
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide in relation to atropine resistant vasodilatation in the submaxillary gland of the cat.
Bloom SR; Edwards AV
J Physiol; 1980 Mar; 300():41-53. PubMed ID: 7381792
[TBL] [Abstract][Full Text] [Related]
14. Delta-9-Tetrahydrocannabinol: effect on mitochondrial swelling of different tissues of rat.
Banerji A; Poddar MK; Ghosh JJ
Methods Find Exp Clin Pharmacol; 1985 Jul; 7(7):351-6. PubMed ID: 2997559
[TBL] [Abstract][Full Text] [Related]
15. Effects of reducing submandibular blood flow on secretory responses to parasympathetic stimulation in anaesthetized cats.
Hanna SJ; Brelen ME; Edwards AV
Exp Physiol; 1999 Jul; 84(4):677-87. PubMed ID: 10481225
[TBL] [Abstract][Full Text] [Related]
16. Expression of vasoactive intestinal polypeptide receptor mRNA and secretory regulation by vasoactive intestinal polypeptide in rat submandibular and sublingual salivary glands.
Takai N; Yoshida Y; Shida T; Kondo E; Ueda Y; Kiyama H; Tohyama M
Arch Oral Biol; 1997 Mar; 42(3):197-204. PubMed ID: 9188989
[TBL] [Abstract][Full Text] [Related]
17. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol.
Beardsley PM; Scimeca JA; Martin BR
J Pharmacol Exp Ther; 1987 May; 241(2):521-6. PubMed ID: 3033218
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholine synthesis, muscarinic receptor subtypes, neuropeptides and secretion of ferret salivary glands with special reference to the zygomatic gland.
Khosravani N; Ekman R; Ekström J
Arch Oral Biol; 2007 May; 52(5):417-26. PubMed ID: 17123459
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of FSH-stimulated cAMP accumulation by delta 9-tetrahydrocannabinol in cultured rat granulosa cells.
Treinen KA; Sneeden JL; Heindel JJ
Toxicol Appl Pharmacol; 1993 Jan; 118(1):53-7. PubMed ID: 8381567
[TBL] [Abstract][Full Text] [Related]
20. Studies on the salivary secretion induced by substance P in perfused submandibular gland of rat.
Ueha T; Nemoto A; Kurihara K
Proc Finn Dent Soc; 1989; 85(4-5):345-53. PubMed ID: 2483967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
